Morgan Stanley’s (MS) Buy Rating Reaffirmed at Keefe, Bruyette & Woods

Keefe, Bruyette & Woods reiterated their buy rating on shares of Morgan Stanley (NYSE:MS) in a report released on Thursday. Keefe, Bruyette & Woods currently has a $62.00 price objective on the financial services provider’s stock.

Several other analysts have also weighed in on MS. Atlantic Securities raised Morgan Stanley from a neutral rating to an overweight rating and set a $61.00 price objective on the stock in a research note on Wednesday, January 10th. Credit Suisse Group raised Morgan Stanley to a buy rating and set a $58.00 price objective on the stock in a research note on Thursday, January 4th. Zacks Investment Research lowered Morgan Stanley from a buy rating to a hold rating in a research note on Tuesday, March 20th. JPMorgan Chase reaffirmed a buy rating and issued a $60.00 price objective on shares of Morgan Stanley in a research note on Thursday, March 15th. Finally, UBS raised Morgan Stanley to an overweight rating in a research note on Wednesday, January 10th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company. The company has a consensus rating of Buy and an average price target of $54.69.

How to Become a New Pot Stock Millionaire

NYSE:MS opened at $53.04 on Thursday. The stock has a market capitalization of $95,039.51, a P/E ratio of 14.73, a price-to-earnings-growth ratio of 0.91 and a beta of 1.54. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 2.75. Morgan Stanley has a twelve month low of $40.43 and a twelve month high of $59.38.

Morgan Stanley (NYSE:MS) last released its quarterly earnings data on Thursday, January 18th. The financial services provider reported $0.84 earnings per share for the quarter, beating the consensus estimate of $0.77 by $0.07. The business had revenue of $9.50 billion for the quarter, compared to analyst estimates of $9.25 billion. Morgan Stanley had a return on equity of 10.07% and a net margin of 14.10%. Morgan Stanley’s revenue was up 5.3% compared to the same quarter last year. During the same period last year, the firm posted $0.81 earnings per share. equities analysts predict that Morgan Stanley will post 4.52 EPS for the current fiscal year.

In related news, insider Daniel A. Simkowitz sold 87,050 shares of Morgan Stanley stock in a transaction that occurred on Wednesday, February 14th. The stock was sold at an average price of $53.55, for a total value of $4,661,527.50. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Chairman James P. Gorman sold 100,000 shares of Morgan Stanley stock in a transaction that occurred on Thursday, February 15th. The stock was sold at an average price of $55.34, for a total value of $5,534,000.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 239,254 shares of company stock worth $13,085,019. 0.35% of the stock is owned by insiders.

Several institutional investors have recently bought and sold shares of the stock. ValueAct Holdings L.P. lifted its stake in shares of Morgan Stanley by 0.4% in the fourth quarter. ValueAct Holdings L.P. now owns 17,959,620 shares of the financial services provider’s stock worth $942,341,000 after acquiring an additional 75,000 shares during the period. Geode Capital Management LLC lifted its stake in shares of Morgan Stanley by 1.4% in the fourth quarter. Geode Capital Management LLC now owns 14,948,683 shares of the financial services provider’s stock worth $782,739,000 after acquiring an additional 206,318 shares during the period. Bank of New York Mellon Corp lifted its stake in shares of Morgan Stanley by 14.2% in the fourth quarter. Bank of New York Mellon Corp now owns 12,643,249 shares of the financial services provider’s stock worth $663,392,000 after acquiring an additional 1,569,202 shares during the period. The Manufacturers Life Insurance Company increased its holdings in Morgan Stanley by 2.5% in the fourth quarter. The Manufacturers Life Insurance Company now owns 12,276,170 shares of the financial services provider’s stock worth $644,130,000 after purchasing an additional 299,060 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in Morgan Stanley by 18.3% in the third quarter. Dimensional Fund Advisors LP now owns 11,816,768 shares of the financial services provider’s stock worth $569,213,000 after purchasing an additional 1,828,697 shares in the last quarter. 86.06% of the stock is currently owned by institutional investors.

WARNING: This piece of content was reported by Ticker Report and is owned by of Ticker Report. If you are reading this piece of content on another website, it was stolen and reposted in violation of United States and international copyright & trademark laws. The correct version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3342173/morgan-stanleys-ms-buy-rating-reaffirmed-at-keefe-bruyette-woods.html.

About Morgan Stanley

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. The company operates through three segments: Institutional Securities, Wealth Management, and Investment Management.

Analyst Recommendations for Morgan Stanley (NYSE:MS)

Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Comparing ConvergeOne  & AgroFresh Solutions
Comparing ConvergeOne & AgroFresh Solutions
Analysts Set $59.00 Target Price for pdvWireless
Analysts Set $59.00 Target Price for pdvWireless
$559.12 Million in Sales Expected for Ferroglobe  This Quarter
$559.12 Million in Sales Expected for Ferroglobe This Quarter
Financial Contrast: NXT-ID  versus Allegion
Financial Contrast: NXT-ID versus Allegion
Head-To-Head Contrast: ReWalk Robotics  versus Invacare
Head-To-Head Contrast: ReWalk Robotics versus Invacare
Ethereum Cash Trading 178.8% Higher  Over Last Week
Ethereum Cash Trading 178.8% Higher Over Last Week


© 2006-2018 Ticker Report. Google+.